tradingkey.logo
tradingkey.logo
Search

Procept Biorobotics Corp

PRCT
Add to Watchlist
22.370USD
+1.750+8.49%
Close 11-09 16:00(ET)
1.28BMarket Cap
LossP/E TTM

Today

+8.49%

5 Days

+15.07%

1 Month

+21.58%

6 Months

-11.93%

Year to Date

-28.89%

1 Year

-29.92%

Key Figures

20.730Open
22.600High
134.60KVolume
LossP/E TTM
LossP/E Dynamic
--Dividend TTM
0.23%Turnover Ratio
20.620Prev. Close
19.410Low
2.96MTurnover
LossP/E Static
3.89P/B
0.00%Div Yield TTM
-20.36%ROA
38.11052wk High
0.07Volume Ratio
-91.41MNet Profit
57.27MShares
-1.8301EPS TTM
0.85Beta
-27.81%ROE
16.66552wk Low
15.47%Amplitude
66.28%Gross Margin
1.28BMarket Cap
3.20Reward/Risk
4.13%Risk Rate
Recent
Transcripts
More news coming soon, stay tuned...

Procept Biorobotics Corp's Score

-0.13vs previous score
Forecast6.67
Financial Health7.15
Technical5.08
Valuation Dimensions8.21
Institutional Confidence10.00
Risk Assessment5.14

Media Coverage

Coverage Level

Very Low
Very High
Positive+

Analyst Rating

Strong Buy
Buy
Hold
Sell
Strong Sell
HoldCurrent Rating
24.571Target Price
+27.98%Upside Space
Current Rating2026-112026-102026-092026-082026-072026-062026-052026-04
Strong Buy11223333
Buy44587777
Hold99754443
Sell11111111
Strong Sell00000000

Procept Biorobotics Corp Technical Analysis

1m
5m
15m
30m
1h
2h
4h
D
W
M
1m
5m
15m
D
Technical Indicators
Buy
Summary
Buy
Moving Average
Strong buy

Procept Biorobotics Corp Latest Earnings Call Transcripts

PROCEPT BioRobotics (PRCT) Q3 2026 Earnings Call: Hydros Drives Utilization Growth

PROCEPT BioRobotics Q3 2026 earnings call: revenue rose 18% to $98.3 million, Hydros utilization led growth, and 2026 guidance was maintained.

Financial Indicators

Currency: USD
Quarterly
Quarterly
Annual
Relevant data have not been disclosed by the company yet.
Currency: USD
Quarterly
Quarterly
Annual
Relevant data have not been disclosed by the company yet.

Earnings

Next reporting date
--
Reporting Period
2026Q3
Earnings / Forecast
-0.46/-0.39
Revenue / Forecast
98.29M/102.56M

Procept Biorobotics Corp Profile

SectorHealthcare Equipment & Supplies
Ticker SymbolPRCT
Number of employees756
CountryUnited States of America

Ownership

ShareholdersProportion
Fidelity Management & Research Company LLC8.10%
BlackRock Institutional Trust Company, N.A.6.66%
AllianceBernstein L.P.5.95%
T. Rowe Price Investment Management, Inc.5.75%
Shareholder TypesProportion
Investment Advisor62.23%
Investment Advisor/Hedge Fund27.95%
Hedge Fund8.01%
Research Firm3.63%

FAQs

What is the current price of Procept Biorobotics Corp (PRCT)?

The current price of Procept Biorobotics Corp (PRCT) is 22.37.

What is the symbol of Procept Biorobotics Corp?

The ticker symbol of Procept Biorobotics Corp is PRCT.

What is the 52-week high of Procept Biorobotics Corp?

The 52-week high of Procept Biorobotics Corp is 38.11.

What is the 52-week low of Procept Biorobotics Corp?

The 52-week low of Procept Biorobotics Corp is 16.66.

What is the market capitalization of Procept Biorobotics Corp?

The market capitalization of Procept Biorobotics Corp is 1.28B.

Is Procept Biorobotics Corp (PRCT) currently rated as Buy, Hold, or Sell?

According to analysts, Procept Biorobotics Corp (PRCT) has an overall rating of signal_hold, with a price target of 24.57.

What is the Earnings Per Share (EPS TTM) of Procept Biorobotics Corp (PRCT)?

The Earnings Per Share (EPS TTM) of Procept Biorobotics Corp (PRCT) is -1.83.
tradingkey.logo
Risk Warning: Our Website and Mobile App provides only general information on certain investment products. Finsights does not provide, and the provision of such information must not be construed as Finsights providing, financial advice or recommendation for any investment product.
Investment products are subject to significant investment risks, including the possible loss of the principal amount invested and may not be suitable for everyone. Past performance of investment products is not indicative of their future performance.
Finsights may allow third party advertisers or affiliates to place or deliver advertisements on our Website or Mobile App or any part thereof and may be compensated by them based on your interaction with the advertisements.
© Copyright: FINSIGHTS MEDIA PTE. LTD. All Rights Reserved.